These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
315 related articles for article (PubMed ID: 23888949)
1. Utility of MLH1 methylation analysis in the clinical evaluation of Lynch Syndrome in women with endometrial cancer. Bruegl AS; Djordjevic B; Urbauer DL; Westin SN; Soliman PT; Lu KH; Luthra R; Broaddus RR Curr Pharm Des; 2014; 20(11):1655-63. PubMed ID: 23888949 [TBL] [Abstract][Full Text] [Related]
2. Combined Microsatellite Instability, MLH1 Methylation Analysis, and Immunohistochemistry for Lynch Syndrome Screening in Endometrial Cancers From GOG210: An NRG Oncology and Gynecologic Oncology Group Study. Goodfellow PJ; Billingsley CC; Lankes HA; Ali S; Cohn DE; Broaddus RJ; Ramirez N; Pritchard CC; Hampel H; Chassen AS; Simmons LV; Schmidt AP; Gao F; Brinton LA; Backes F; Landrum LM; Geller MA; DiSilvestro PA; Pearl ML; Lele SB; Powell MA; Zaino RJ; Mutch D J Clin Oncol; 2015 Dec; 33(36):4301-8. PubMed ID: 26552419 [TBL] [Abstract][Full Text] [Related]
3. Germline MLH1 Mutations Are Frequently Identified in Lynch Syndrome Patients With Colorectal and Endometrial Carcinoma Demonstrating Isolated Loss of PMS2 Immunohistochemical Expression. Dudley B; Brand RE; Thull D; Bahary N; Nikiforova MN; Pai RK Am J Surg Pathol; 2015 Aug; 39(8):1114-20. PubMed ID: 25871621 [TBL] [Abstract][Full Text] [Related]
4. Universal endometrial cancer tumor typing: How much has immunohistochemistry, microsatellite instability, and MLH1 methylation improved the diagnosis of Lynch syndrome across the population? Kahn RM; Gordhandas S; Maddy BP; Baltich Nelson B; Askin G; Christos PJ; Caputo TA; Chapman-Davis E; Holcomb K; Frey MK Cancer; 2019 Sep; 125(18):3172-3183. PubMed ID: 31150123 [TBL] [Abstract][Full Text] [Related]
5. Efficient molecular screening of Lynch syndrome by specific 3' promoter methylation of the MLH1 or BRAF mutation in colorectal cancer with high-frequency microsatellite instability. Nakagawa H; Nagasaka T; Cullings HM; Notohara K; Hoshijima N; Young J; Lynch HT; Tanaka N; Matsubara N Oncol Rep; 2009 Jun; 21(6):1577-83. PubMed ID: 19424639 [TBL] [Abstract][Full Text] [Related]
6. Clinicopathologic implications of DNA mismatch repair status in endometrial carcinomas. Shikama A; Minaguchi T; Matsumoto K; Akiyama-Abe A; Nakamura Y; Michikami H; Nakao S; Sakurai M; Ochi H; Onuki M; Satoh T; Oki A; Yoshikawa H Gynecol Oncol; 2016 Feb; 140(2):226-33. PubMed ID: 26644264 [TBL] [Abstract][Full Text] [Related]
7. Screening for Lynch syndrome (hereditary nonpolyposis colorectal cancer) among endometrial cancer patients. Hampel H; Frankel W; Panescu J; Lockman J; Sotamaa K; Fix D; Comeras I; La Jeunesse J; Nakagawa H; Westman JA; Prior TW; Clendenning M; Penzone P; Lombardi J; Dunn P; Cohn DE; Copeland L; Eaton L; Fowler J; Lewandowski G; Vaccarello L; Bell J; Reid G; de la Chapelle A Cancer Res; 2006 Aug; 66(15):7810-7. PubMed ID: 16885385 [TBL] [Abstract][Full Text] [Related]
8. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Walsh MD; Cummings MC; Buchanan DD; Dambacher WM; Arnold S; McKeone D; Byrnes R; Barker MA; Leggett BA; Gattas M; Jass JR; Spurdle AB; Young J; Obermair A Clin Cancer Res; 2008 Mar; 14(6):1692-700. PubMed ID: 18310315 [TBL] [Abstract][Full Text] [Related]
10. Association of tumor morphology with mismatch-repair protein status in older endometrial cancer patients: implications for universal versus selective screening strategies for Lynch syndrome. Rabban JT; Calkins SM; Karnezis AN; Grenert JP; Blanco A; Crawford B; Chen LM Am J Surg Pathol; 2014 Jun; 38(6):793-800. PubMed ID: 24503759 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of clinical criteria for the identification of Lynch syndrome among unselected patients with endometrial cancer. Bruegl AS; Djordjevic B; Batte B; Daniels M; Fellman B; Urbauer D; Luthra R; Sun C; Lu KH; Broaddus RR Cancer Prev Res (Phila); 2014 Jul; 7(7):686-97. PubMed ID: 24771847 [TBL] [Abstract][Full Text] [Related]
16. Importance of PCR-based Tumor Testing in the Evaluation of Lynch Syndrome-associated Endometrial Cancer. Bruegl AS; Kernberg A; Broaddus RR Adv Anat Pathol; 2017 Nov; 24(6):372-378. PubMed ID: 28820751 [TBL] [Abstract][Full Text] [Related]
17. Universal screening for Lynch syndrome in endometrial cancers: frequency of germline mutations and identification of patients with Lynch-like syndrome. Dillon JL; Gonzalez JL; DeMars L; Bloch KJ; Tafe LJ Hum Pathol; 2017 Dec; 70():121-128. PubMed ID: 29107668 [TBL] [Abstract][Full Text] [Related]
18. Lynch syndrome-associated endometrial carcinoma with MLH1 germline mutation and MLH1 promoter hypermethylation: a case report and literature review. Yokoyama T; Takehara K; Sugimoto N; Kaneko K; Fujimoto E; Okazawa-Sakai M; Okame S; Shiroyama Y; Yokoyama T; Teramoto N; Ohsumi S; Saito S; Imai K; Sugano K BMC Cancer; 2018 May; 18(1):576. PubMed ID: 29783979 [TBL] [Abstract][Full Text] [Related]
19. Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer. Bosse T; ter Haar NT; Seeber LM; v Diest PJ; Hes FJ; Vasen HF; Nout RA; Creutzberg CL; Morreau H; Smit VT Mod Pathol; 2013 Nov; 26(11):1525-35. PubMed ID: 23702729 [TBL] [Abstract][Full Text] [Related]
20. Redundant DNA methylation in colorectal cancers of Lynch-syndrome patients. Alemayehu A; Sebova K; Fridrichova I Genes Chromosomes Cancer; 2008 Oct; 47(10):906-14. PubMed ID: 18618713 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]